PM: decision on the application for modification of an agreed PIP
Decision date
Compliance procedure number
EMEA-C-001864-PIP01-15-M07
Compliance opinion date
Compliance outcome
Positive
Decision
P/0214/2022 : EMA decision of 10 June 2022 on the acceptance of a modification of an agreed paediatric investigation plan for lanadelumab (Takhzyro), (EMEA-001864-PIP01-15-M07)